Skip to content

Clinical trials

Phase 3 Carcinoma, Non-Small-Cell Lung trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Phase: Phase 3 Country / region: China Clear all

309 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20041
20054
20068
20077
20087
20099
20105
20118
20124
20139
20147
201514
201612
201714
201821
201916
202017
202126
202219
202324
202434
202527
202614

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed98
Recruiting68
Active, not recruiting66
Unknown status45
Terminated22
Not yet recruiting7
Enrolling by invitation3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche24
AstraZeneca22
Merck Sharp & Dohme LLC21
Bristol-Myers Squibb14
Eli Lilly and Company10
Pfizer10
Sun Yat-sen University8
BeiGene7
Boehringer Ingelheim7
Novartis Pharmaceuticals7

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung309
Lung Neoplasms26
Carcinoma9
Neoplasm Metastasis9
Brain Neoplasms7
Neoplasms6
Bronchial Neoplasms5
Lung Diseases5
Thoracic Neoplasms5
Carcinoma, Bronchogenic4

Trials

Showing 1 to 25 of 309. Each trial links to its page on Pharma Observatory.

209 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.